The purpose of this pilot study is to gather preliminary data on the (1) contribution of the understudied drug metabolizing enzyme, UDP-glucuronosyltransferase (UGT) 2B17, to the metabolism of a widely used medication, diclofenac, and (2) impact of the UGT2B17 inhibitor and natural product, curcumin, on diclofenac pharmacokinetics. Results will inform future studies aimed to assess the effects of UGT2B17 genetic polymorphisms and co-consumed xenobiotics on the pharmacokinetics and toxicity risk of diclofenac and other UGT2B17 drug substrates.
Age range
18 Years – 65 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Diclofenac area under the concentration vs. time curve (AUC) in UGT2B17 extensive metabolizers (EMs)
Timeframe: 0-12 hours
Diclofenac AUC in poor metabolizers (PMs)
Timeframe: 0-12 hours
Diclofenac AUC in EMs in the presence of curcumin
Timeframe: 0-12 hours
Diclofenac maximum concentration (Cmax) in EMs
Timeframe: 0-12 hours
Diclofenac Cmax in PMs
Timeframe: 0-12 hours
Diclofenac Cmax in EMs in the presence of curcumin
Timeframe: 0-12 hours
Diclofenac renal clearance (CLr) in EMs
Timeframe: 0-12 hours
Diclofenac CLr in PMs
Timeframe: 0-12 hours
Diclofenac CLr in EMs in the presence of curcumin
Timeframe: 0-12 hours
Diclofenac half-life (t1/2) in EMs
Timeframe: 0-12 hours
Diclofenac half-life (t1/2) in PMs
Timeframe: 0-12 hours
Diclofenac half-life (t1/2) in EMs in the presence of curcumin
Timeframe: 0-12 hours